Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2024
Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple MyelomaTanvi H Patel, Frits van Rhee, Samer Al Hadidi
Cancers|December 24, 2021
Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma PatientsSamrat Roy Choudhury, Cody Ashby, Fenghuang Zhan, et al.
Diagnostic Pathology|February 22, 2018
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencingJonathon H Gralewski, Ginell R Post, Frits van Rhee, et al.
Critical Reviews in Oncogenesis|June 19, 2014
Clinical grade purification and expansion of natural killer cellsNatalia Lapteva, Susann M Szmania, Frits van Rhee, et al.
Haematologica|June 12, 2025
Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu miceWen Ling, Maurizio Zangari, Frits Van Rhee, et al.
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.
Cureus|July 20, 2026
Necrobiotic Xanthogranuloma Associated With IgG Kappa Smoldering Myeloma Presenting as Vision-Threatening Orbital Disease: Clinical Response to Plasma Cell-Directed TherapyHira I Cheema, Maurizio Zangari, Carolina Schinke, et al.
JAMA Network Open|April 20, 2022
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant NeoplasmsSamer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Cancers|July 28, 2026
Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched AnalysisAnushareddy Muddasani, Sharmilan Thanendrarajan, Maurizio Zangari, et al.
Cancer Treatment Reviews|April 22, 2017
Immunologic approaches for the treatment of multiple myelomaLeo Rasche, Niels Weinhold, Gareth J Morgan, et al.
Pageof 24